An observational study in Glaucoma, Open-Angle and Pseudo Exfoliation Syndrome, sponsored by St. Erik Eye Hospital. Terminated at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-05-13.
Sponsored by St. Erik Eye Hospital · Observational
Among 15 studies in Glaucoma, Open-Angle with a site in Sweden — 3 open to participants now, 5 under way, none of them phase 3. Glaucoma, Open-Angle · Sweden.
Among the 15 studies in Glaucoma, Open-Angle with a site in Sweden, this one is the only one that started in 2018, is one of 5 observational ones, and was the 7th registered.
924 studies on the registry are indexed under Glaucoma, Open-Angle; 116 are open to participants now.
Browse Glaucoma, Open-Angle studies →3 of the 15 studies in Glaucoma, Open-Angle with a site in Sweden are open now. Recruiting first, the newest first:
Karolinska Institutet · Sites in Sweden
Ages 18+
Vastra Gotaland Region · Sites in Sweden
Ages 18+
Vastra Gotaland Region · Sites in Sweden
Ages 18+
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 83 Glaucoma, Open-Angle studies recruiting now, 64 (77%) set no upper age limit and 5 (6%) stop at 75 or younger; 5 take children under 18; 11 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 1992; this study’s year is marked. 1 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 50 is below the median of 101 across 184 observational studies indexed under Glaucoma, Open-Angle.
Median enrollment 329 across the 9 interventional studies, 60 across the 5 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 15 have an industry lead sponsor. The 8 most frequent:
St. Erik Eye Hospital is the lead sponsor of 13 studies on the registry; none are open to participants now.
St. Erik Eye Hospital has 4 studies filed under Glaucoma, Open-Angle — fewer than ten, so there is no comparison to draw.
1 of the studies in Glaucoma, Open-Angle with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06885827Karolinska InstitutetVitamin Mix (B6, B9, B12, And Choline) For Glaucoma Patients | 2027-03-31 |
Add it to your calendar (.ics) → With an account.
Among the 15 studies in Glaucoma, Open-Angle with a site in Sweden, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to investigate how much trabeculectomy influences intraocular pressure (IOP) fluctuations measured with iCare Home rebound tonometry (RTHome) in patients with primary open-angle glaucoma (POAG) or pseudo-exfoliation glaucoma (PEX).
Fifty glaucoma patients (POAG and PEX) planned for trabeculectomy will be recruited.
At baseline, patients will be trained to use the iCare Home tonometer (RTHome), a handheld device based on rebound tonometry and designed for patients to use at home. After the training session and when patients feel confident, a measurement will be recorded. At the same visit, a new measurement will be obtained by the study staff, an optometrist or a nurse, using the same device. No IOP values will be visible for the examiner at that point. A single IOP measurement will be obtained by the same study staff using Goldmann applanation tonometry (GAT). Patients will come for a second visit where new measurements will be made in the same way as at baseline.
In between visits, patients will borrow the iCare Home tonometer to measure their IOP at 06 and 10 am, and at 2, 6 and 10 pm during three consecutive days to obtain an IOP curve.
Two-three months after trabeculectomy, a new IOP curve will be obtained following the same procedure as pre-operatively. There will be no restrictions in patients' daily activities regarding diet, physical activity or slee. If patients use any eyedrops, they will continue to use them as prescribed.
Consecutive male and female patients, older than 18 y.o., at St Erik's Eye Hospital in Stockholm, Sweden, diagnosed with POAG or PXG and listed for a trabeculectomy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Lowering of IOP levels after trabeculectomy
Mean (SD) IOP pre- and post trabeculectomy
Time frame: 2-3 months
Lowering of IOP fluctuations after trabeculectomy
Mean (SD) IOP range pre- and post trabeculectomy
Time frame: 2-3 months
Ran from Feb 2018 to primary completion in Mar 2021, 36 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in May 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
St. Erik Eye Hospital